Physician profile
Richard Hammond
NPI 1457328320
$9,150.54
in general payments reported to CMS, 2019-2025
15 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $429 · 2021: $3,117 · 2022: $2,913 · 2023: $8.99 · 2024: $1,162 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042 · Travel and Lodging: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.03 |
| Travel and Lodging | $639.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,106.79 | 2019-2022 | |
| Paragon 28, INC. | $1,669.41 | 2021-2022 | |
| Great Lakes Orthopedics | $1,441.51 | 2019-2021 | |
| True North Surgical INC | $744.54 | 2022 | |
| Medline Industries LP | $639.99 | 2024 | |
| Stryker Corporation | $454.88 | 2022-2025 | Prostep Mica, Infinity Adaptis, Citrefix |
| Depuy Synthes Sales INC. | $275.29 | 2021-2025 | Va-Lcp |
| Smith+Nephew, INC. | $268.34 | 2019-2025 | Grafix Pl, Grafix, Stravix Mesh |
| Anika Therapeutics, INC. | $155.69 | 2022 | |
| Bone Support INC. | $125.85 | 2025 | Ceramentbone Void Filler, Cerament G |
| Abbott Laboratories | $120.67 | 2024 | Proclaim |
| Linvatec Corporation | $62.86 | 2024 | Biobrace 23mm |
| Wright Medical Technology, INC. | $52.79 | 2020 | |
| Organogenesis INC. | $22.94 | 2021 | |
| Polynovo North America LLC | $8.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Hammond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.